Welcome Guest | Register / Login

Global Botulinum Toxin Market: Size, Trends and Forecasts (2018-2022 Edition)

Table of Contents

1. Executive Summary

2. Introduction
2.1 Botulinum Toxin: An Overview
2.2 Botulinum Toxin: Indications Overview
2.3 Botulinum Toxin: Products Overview

3. Global Market Analysis
3.1 Global Botulinum Toxin Market: An Analysis
3.1.1 Global Botulinum Toxin Market by Value
3.1.2 Global Botulinum Toxin Market by Application (Theapeutic and Aesthetic)
3.1.3 Global Botulinum Toxin Market by Products (Botox, Dysport, Xeomin and Others)
3.1.4 Global Botulinum Toxin Market by Region (The US, Europe, Japan, Asia (excluding Japan) and Rest of the World)
3.2 Global Botulinum Toxin Market: Application Analysis
3.2.1 Global Therapeutic Botulinum Toxin Market by Value
3.2.2 Global Therapeutic Botulinum Toxin Market by Indication
3.2.3 Global Cosmetic/Aesthetic Botulinum Toxin Market by Value
3.2.4 Global Cosmetic/Aesthetic Botulinum Toxin Market by Number of Procedures
3.3 Global Botulinum Toxin Market: Product Analysis
3.3.1 Global Botox Market by Value
3.3.2 Global Dysport Market by Value
3.3.3 Global Xeomin Market by Value

4. Regional Market Analysis
4.1 The US Botulinum Toxin Market: An Analysis
4.1.1 The US Botulinum Toxin Market by Value
4.1.2 The US Botulinum Toxin Market by Application (Therapeutic and Aesthetic)
4.2 Europe Botulinum Toxin Market: An Analysis
4.1.1 Europe Botulinum Toxin Market by Value
4.2.2 Europe Botulinum Toxin Market by Application (Therapeutic and Aesthetic)
4.3 Japan Botulinum Toxin Market: An Analysis
4.3.1 Japan Botulinum Toxin Market by Value
4.3.2 Japan Botulinum Toxin Market by Application Application (Therapeutic and Aesthetic)
4.4 Asia (Excluding Japan) Botulinum Toxin Market: An Analysis
4.4.1 Asia (Excluding Japan) Botulinum Toxin Market by Value
4.4.2 Korea Botulinum Toxin Market by Value
4.4.3 China Botulinum Toxin Market by Value

5. Market Dynamics
5.1 Growth Drivers
5.1.1 Ageing Population
5.1.2 Escalating Number of Plastic Surgeons
5.1.3 Upsurge in Facial Aesthetics Procedures
5.1.4 Rising Alternative of Non-Surgical Procedures
5.1.5 Increasing Healthcare Spending in Emerging Markets
5.2 Challenges
5.2.1 Potential Health Risk Associated with Botulinum Toxin
5.2.2 Botulinum Toxins As  Bio-terror Threat
5.3 Market Trends
5.3.1 Rise In Medical Tourism
5.3.2 Reduced Safety Concerns and Simple & Instant Characteristic
5.3.3 Scope of Botulinum Toxin in Treatment of Necrotizing Fasciitis

6. Competitive Landscape
6.1 Global Botulinum Toxin Market by Players
6.1.1 Global Botulinum Toxin  Market Share by Players
6.1.2 The US Botulinum Toxin Market Share by Players
6.1.3 Europe Botulinum Toxin Market Share by Players
6.1.4 Global Botulinum Toxin  Market Key Development for Players
6.2 Korea Botulinum Toxin  Market  by Players
6.2.1 Korea Botulinum Toxin  Market Share by Players
6.2.2 Korea Botulinum Toxin  Market Players by Sales

7. Company Profiles
7.1 Allergan Plc.
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategy
7.2 Ipsen
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy
7.3 Revance Therapeutics, Inc.
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategy

List of Tables

Table 1: Applicable Indications of Botulinum Toxin
Table 2: Major Non-surgical Facial Aesthetic Procedures
Table 3: Global Botulinum Toxin Market Key Development Schedule for Players

List of Figures

Figure 1: Types of Botulinum Toxin
Figure 2: Botulinum Toxin Products
Figure 3: Global Botulinum Toxin Market by Value; 2014-2017 (US$ Billion)
Figure 4: Global Botulinum Toxin Market by Value; 2018-2022 (US$ Billion)
Figure 5: Global Botulinum Toxin Market by Application; 2017 (Percentage,%)
Figure 6: Global Botulinum Toxin Market by Products;2017 (Percentage,%)
Figure 7: Global Botulinum Toxin Market by Region;2017 (Percentage,%)
Figure 8: Global Therapeutic Botulinum Toxin Market by Value; 2016-2022 (US$ Billion)
Figure 9: Global Therapeutic Botulinum Toxin Market by Indication; 2017 (Percentage,%)
Figure 10: Global Cosmetic/Aesthetic Botulinum Toxin Market by Value; 2016-2022 (US$ Billion)
Figure 11: Global Cosmetic/Aesthetic Botulinum Toxin Market Number of Procedures by Countries; 2016 (Percentage,%)
Figure 12: Global Botox Market by Value; 2016-2022 (US$ Billion)
Figure 13: Global Dysport Market by Value; 2016-2022 (US$ Billion)
Figure 14: Global Xeomin Market by Value; 2016-2022 (US$ Billion)
Figure 15: The US Botulinum Toxin Market by Value; 2014-2017(US$ Billion)
Figure 16: The US Botulinum Toxin Market by Value; 2018-2022 (US$ Billion)
Figure 17: The US Botulinum Toxin Market by Application; 2014-2017 (US$ Billion)
Figure 18: The US Botulinum Toxin Market by Application; 2018-2022 (US$ Billion)
Figure 19: Europe Botulinum Toxin Market by Value; 2014-2017(US$ Billion)
Figure 20: Europe Botulinum Toxin Market by Value; 2018-2022 (US$ Billion)
Figure 21: Europe Botulinum Toxin Market by Application; 2014-2017 (US$ Billion)
Figure 22: Europe Botulinum Toxin Market by Application; 2018-2022 (US$ Billion)
Figure 23: Japan Botulinum Toxin Market by Value; 2014-2017(US$ Million)
Figure 24: Japan Botulinum Toxin Market by Value; 2018-2022 (US$ Million)
Figure 25: Japan Botulinum Toxin Market by Application; 2014-2017 (US$ Million)
Figure 26: Japan Botulinum Toxin Market by Application; 2018-2022 (US$ Million)
Figure 27: Asia (Excluding Japan) Botulinum Toxin Market by Value; 2014-2017(US$ Million)
Figure 28: Asia (Excluding Japan) Botulinum Toxin Market by Value; 2018-2022 (US$ Million)
Figure 29: Korea Botulinum Toxin Market by Value; 2014-2017(US$ Million)
Figure 30: Korea Botulinum Toxin Market by Value; 2018-2022 (US$ Million)
Figure 31: China Botulinum Toxin Market by Value; 2014-2017(US$ Million)
Figure 32: China Botulinum Toxin Market by Value; 2018-2022 (US$ Million)
Figure 33: Global Population by Age Groups; 2015-2030 (Million)
Figure 34: Number of Plastic Surgeons by Nations; 2016-2017 (Thousand)
Figure 35: Global Number of Facial Aesthetic Procedures; 2010-2017 (Percentage, %)
Figure 36: Global Healthcare Expenditure; 1995-2022 (US$ Trillion)
Figure 37: Global Botulinum Toxin Market Share by Players; 2017 (Percentage,%)
Figure 38: The US Botulinum Toxin Market Share by Players; 2017 (Percentage,%)
Figure 39: Europe Botulinum Toxin Market Share by Players; 2017 (Percentage,%)
Figure 40: Korea Botulinum Toxin Market Share by Players; 2016 (Percentage,%)
Figure 41: Korea Botulinum Toxin Market Players by Sales; 2012-2016 (US$ Million)
Figure 42: Allergan Plc. Revenue; 2013-2017 (US$ Billion)
Figure 43: Allergan Plc. Revenue by Segments; 2017 (Percentage,%)
Figure 44: Ipsen Net Sales; 2012-2016 (US$ Billion)
Figure 45: Ipsen Net Sales by Segments; 2017 (Percentage,%)
Figure 46: Ipsen Net Sales by Regions; 2017 (Percentage,%)
Figure 47: Revance Therapeutics, Inc. Revenue; 2013-2017 (US$ Thousand)
Figure 48: Revance Therapeutics, Inc. Research and Development Expenditure; 2013-2017 (US$ Million)

Single User License: Report will be emailed in PDF format and can be accessed by a specific user. This License type allows the report to be Printed.
Corporate/Global User License: Report will be emailed in PDF format and allows all employees within the organization to access it.  This License type allows the report to be Printed.
Why http://www.marketreportsonline.com/
Published By :Daedal Research
Price
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy